Metastat Insights
Back to Medical Devices

Surgical 3D Printing Market

Surgical 3D Printing Market Size, Share, By Component (Equipment, Materials, Services & Software), By Application (External Wearable Devices, Tissue Engineering, Implants, and Clinical Study Devices), By Technology (Electronic Beam Melting (EBM), Laser Beam Melting, Photopolymerization, Droplet Deposition (DD), and Others), Industry Analysis, Growth, Trends, and Forecast, 2026-2033

Report ID

MSI-2298

Published

February 3, 2026

Pages

312 Pages

Format

Report Details

Comprehensive Market Analysis And Insights

End of Report Overview

Frequently Asked Questions

Find answers to common questions about this report

Top players operating in the Surgical 3D Printing industry includes 3D Systems Corporation, Stratasys Ltd., Envisiontec GmbH, Renishaw plc, EOS GmbH Electro Optical Systems, Materialise NV, 3T Additive Manufacturing Ltd., Arcam AB, Prodways Group, and Concept Laser GmbH

The Surgical 3D Printing market is projected to grow at a CAGR of 17.8% during the forecast period from 2026 to 2033.

According to Metastat Insights analysis, the North America Surgical 3D Printing market size is estimated to reach USD 4623.6 million by 2033.

The Metastat Insights study reveals that the Surgical 3D Printing market size was valued at USD 3369.9 million in 2025.

Medical Devices Research Team

The analysts below cover Medical Devices research at Metastat Insights.

UTKARSH KHIRODKAR

LEAD ANALYST

Utkarsh Khirodkar is a Lead Market Research Analyst at MetaStat Insight, specializing in market intelligence, technology sector assessments, and competitive strategy.

AJAY DEVGIRE

LEAD PRINCIPAL ANALYST, PHARMA AND HEALTHCARE

Food and Beverages · Healthcare · Healthcare IT · Medical Devices

Ajay Devgire is the Lead Healthcare Analyst at MetaStat Insight, leading strategic research and market intelligence initiatives across the global healthcare domain.

What our clients say

Ambulatory surgical centers have very different purchasing cycles for robotic-assisted surgery platforms than major hospital networks. The MetaStat Insight study focused squarely on capital expenditure depreciation, procedural reimbursement pathways, and surgeon training overhead. That operational clarity made it much simpler to validate multi-year procedure growth forecasts against actual ambulatory center adoption patterns.
M

Medtronic

Manager, Surgical Innovations

When planning edge sensor rollouts across refinery environments, generic IoT reports typically miss the harsh-environment certification bottlenecks. MetaStat Insight gave an objective evaluation of ATEX and Class 1 Division 2 hardware availability, along with realistic five-year maintenance cycle cost projections. The comparison of wireless mesh versus private cellular backhaul helped our team pressure-test network reliability models for remote processing facilities.
H

Honeywell

Principal Systems Architect

In the biological seed treatment space, registration timelines vary drastically between the European Union, Brazil, and North America. The MetaStat Insight research handled these cross-border regulatory barriers with genuine nuance, mapping commercialization pathways alongside historical field adoption rates. The segmentation between microbial strains and biochemical active ingredients was particularly well structured.
B

BASF

Market Development Lead, Sustainable Crop Protection Solutions

Related Reports

Explore related market intelligence reports worth reading alongside this one.